Company profile: BenchSci
1.1 - Company Overview
Company description
- Provider of biology-specific multimodal AI for scientific accuracy and scalable, enterprise-grade software to accelerate drug discovery and biomedical research, featuring ASCEND, a GenAI assistant that understands disease biology across therapeutic areas; a Data Foundation with access to comprehensive biomedical datasets (papers, patents, third-party data); and secure integrations of internal pharmaceutical data.
Products and services
- Biology-Specific Multimodal AI: Scientific-grade system that interprets biological experiments from text and figures, designed for accuracy to avoid errors common in generative AI
- ASCEND: Custom-engineered GenAI assistant that understands disease biology across therapeutic areas, accelerating drug discovery using a comprehensive biomedical dataset and multimodal AI
- Data Foundation: Large-scale access to biomedical data—including papers, patents, and third-party datasets—supporting research purposes with comprehensive coverage
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to BenchSci
Tx3
HQ: United States
Website
- Description: Provider of automated quality and compliance SaaS solutions for software testing within Life Science companies, enabling agile adoption and efficient adherence to regulatory requirements such as 21 CFR Part 11. Offerings include Tricentis Tosca, qTest, NeoLoad, LiveCompare, and Data Integrity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tx3 company profile →
Marken
HQ: United States
Website
- Description: Provider of patient-centric clinical trial logistics for the pharmaceutical and life sciences industries, including clinical trial sample delivery, chain of custody shipping, global control center monitoring, real-time clinical shipment tracking, vaccine trial storage, and a home healthcare management system; maintains a leading position in Direct to Patient services and biological sample shipments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Marken company profile →
Research Solutions
HQ: United States
Website
- Description: Provider of full-service document delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Research Solutions company profile →
RxS
HQ: United States
Website
- Description: Provider of end-to-end multi-channel sample management solutions, including LinkedRx for compliant management of pharmaceutical samples across hand-carry and direct-to-practitioner channels; TeleTargetRx contact center CRM for inside sales and sample requests; SampleCentral eSampling portal for healthcare professionals; RxS Engage telesampling and support services; and ClientConnect multi-channel reporting and analytics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RxS company profile →
Parallel 6
HQ: United States
Website
- Description: Provider of cloud-based SaaS solutions for mobile enrollment and patient engagement for clinical trials and clinical research, serving public sector organizations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Parallel 6 company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for BenchSci
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to BenchSci
2.2 - Growth funds investing in similar companies to BenchSci
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for BenchSci
4.2 - Public trading comparable groups for BenchSci
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →